# Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe

> **NCT02127320** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Rosuvastatin 20mg
- **DRUG:** Ezetimibe 10mg
- **DRUG:** Rosuvastatin 20mg + Ezetimibe 10mg

## Key facts

- **NCT ID:** NCT02127320
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-09
- **Final completion:** 2014-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02127320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02127320, "Investigating the Pharmacokinetic Drug Interactions Between Rosuvastatin and Ezetimibe". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02127320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*